Potential Utility of the Mallampati Score for Prediction of Treatment Compliance and Safety Profiles of Patients With Head and Neck Cancer Undergoing Definitive Concurrent Chemoradiotherapy

MLA

Po-Hsu, Su, et al. “Potential Utility of the Mallampati Score for Prediction of Treatment Compliance and Safety Profiles of Patients With Head and Neck Cancer Undergoing Definitive Concurrent Chemoradiotherapy.” Anticancer Research, vol. 42, Oct. 2022, pp. 5609–18. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3875b428691a496f75c431e89ab740b9&authtype=sso&custid=ns315887.

APA

Po-Hsu, S., Chih-Chung, H., Shun-Wen, H., Chia-Yen, H., Kun-Yun, Y., Hung-Ming, W., Chang-Hsien, L., Yu-Ching, L., Joseph Tung-Chieh, C., & Wen-Chi, C. (2022). Potential Utility of the Mallampati Score for Prediction of Treatment Compliance and Safety Profiles of Patients With Head and Neck Cancer Undergoing Definitive Concurrent Chemoradiotherapy. Anticancer Research, 42, 5609–5618.

Chicago

Po-Hsu, Su, Hsu Chih-Chung, Hsueh Shun-Wen, Hung Chia-Yen, Yeh Kun-Yun, Wang Hung-Ming, Lu Chang-Hsien, Lin Yu-Ching, Chang Joseph Tung-Chieh, and Chou Wen-Chi. 2022. “Potential Utility of the Mallampati Score for Prediction of Treatment Compliance and Safety Profiles of Patients With Head and Neck Cancer Undergoing Definitive Concurrent Chemoradiotherapy.” Anticancer Research 42 (October): 5609–18. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....3875b428691a496f75c431e89ab740b9&authtype=sso&custid=ns315887.